PLGA biodegradable nanoparticles containing perphenazine or chlorpromazine hydrochloride: Effect of formulation and release

International Journal of Molecular Sciences

Volumn 15, Issue 12, 2014, Pages 23909-23923

  Halayqa, Mohammed ^a   Domańska, Urszula ^a,b  

^a WARSAW UNIVERSITY OF TECHNOLOGY   (Poland)

^b UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

Chlorpromazine hydrochloride; Controlled drug delivery; Experimental nanomedicine; Perphenazine; Physicochemical properties of nanoparticles; PLGA; Psychotic drugs

Indexed keywords

CHLORPROMAZINE; NANOPARTICLE; PERPHENAZINE; POLYGLACTIN NANOPARTICLE; UNCLASSIFIED DRUG; DELAYED RELEASE FORMULATION; DOPAMINE RECEPTOR BLOCKING AGENT; LACTIC ACID; POLYGLYCOLIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER;

ARTICLE; DENSITY; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; LIGHT SCATTERING; MORPHOLOGY; NANOENCAPSULATION; PARTICLE SIZE; SCANNING ELECTRON MICROSCOPY; ULTRAVIOLET SPECTROPHOTOMETRY; VISCOSITY; CHEMISTRY; DELAYED RELEASE FORMULATION; KINETICS; MEDICINAL CHEMISTRY; PH; ULTRASTRUCTURE;

CHEMISTRY, PHARMACEUTICAL; CHLORPROMAZINE; DELAYED-ACTION PREPARATIONS; DOPAMINE ANTAGONISTS; HYDROGEN-ION CONCENTRATION; KINETICS; LACTIC ACID; NANOPARTICLES; PARTICLE SIZE; PERPHENAZINE; POLYGLYCOLIC ACID;

EID: 84919807863     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms151223909     Document Type: Article

References (33)

1. Cooper, D.L.; Harirforoosh, S. Design and optimization of PLGA-based diclofenac loaded nanoparticles. PLoS One 2014, 9, e87326.
2. Zarrabi, A.; Vossoughi, M.; Alemzadeh, I.; Chitsazi, M.R. Monodispersed polymeric nanoparticles fabrication by electrospray atomization. Int. J. Polym. Mater. 2012, 61, 611-626.
3. Zhou, Y.Y.; Du, Y.Z.; Wang, L.; Zhou, J.P.; Hu, F.Q. Preparation and pharmacodynamics of stearic acid and poly(lactic-co-glycolic acid) grafted chitosan oligosaccharide micelles for 10-hydroxycamptothecin. Int. J. Pharm. 2010, 393, 143-151.
4. Rinaldi, S.; Fortunati, E.; Taddei, M.; Kenny, J.M.; Armentano, I.; Latterini, L. Integrated PLGA-Agnanocomposite systems to control the degradation rate and antibacterial properties. J. Appl. Polym. Sci. 2013, 130, 1185-1193.
5. Pascolo, L.; Bortot, B.; Benseny-Cases, N.; Gianoncelli, A.; Tosi, G.; Ruozi, B.; Rizzardi, K.; de Martino, E.; Vandelli, M.; Severini, G.M. Detection of PLG A-based nanoparticles at a single-cell level by synchrotron radiation FTIR spectromicroscopy and correlation with X-ray fluorescence microscopy, Int. J. Nanomed. 2014, 9, 2791-2801.
6. Kumari, A.; Yadav, S.K.; Yadav, S.C. Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf. B 2010, 75, 1-18.
7. Danhier, F.; Lecouturier, N.; Vromana, B.; Jerome, C.; Marchand-Brynaert, J.; Ferond, O.; Preat, V. Paclitaxelloaded PEGylated PLGA-based nanoparticles: In vitro and in vivo evaluation. J. Control. Release 2009, 133, 11-17.
8. Pelczarska, A.; Delie, F.; Domańska, U.; Carrupt, P.; Martel, S. New high throughput screening method for drug release measurements. Eur. J. Pharm. Biopharm. 2013, 85, 151-157.
9. Song, C.X.; Labhasetwar, V.; Murphy, H.; Qu, X.; Humphrey, W.R.; Shebuski, R.J.; Levy, R.J. Formulation and characterization of biodegradable nanoparticles for intravascular local drug delivery. J. Control. Release 1997, 43, 197-212.
10. Kumar, G.; Sharma, S.; Shafiq, N.; Khuller, G.K.; Malhotra, S. Optimization, in vitro-in vivo evaluation, and short-term torelability of novel levofloxacin-loaded PLGA nanoparticle formulation. J. Pharm. Sci. 2012, 101, 2165-2176.
11. Wang, Y.; Li, P.; Peng, Z.; She, F.H.; Kong, L.X. Microencapsulation of nanoparticles with enhanced drug loading for pH-sensitive oral drug delivery for the treatment of colon cancer. J. Appl. Polym. Sci. 2013, 129, 714-720.
12. Mainardes, R.M.; Evangelista, R.C. PLGA nanopartcles containing praziquantel: Effect of formulation variable on size distribution. Int. J. Pharm. 2005, 290, 137-144.
13. PIENO. Available online: http://www.parkinsons-information-exchange-network-online.com?drugdb/029.html (accessed on October 2014).
14. Samara, M.T.; Cao, H.; Helfer, B.; Davis, J.M.; Leucht, S. Chlorpromazine versus very other antipsychotic for schizophrenia: A systematic review and meta-analysis challenging the dogma of equal efficacy of antipsychotic drugs. Eur. Neuropsychopharmacol. 2014, 24, 1046-1055.
15. Chalikwar, S.S.; Mene, S.B.; Pardeshi, C.V.; Belgamwar, V.S.; Surana, S.J. Self-assembled, chitosan grafted PLGA nanoparticles for intranasal delivery: Design, development and ex vivo characterization. Polym.-Plast. Technol. Eng. 2013, 52, 368-380.
16. Meltzer, H.Y.; Massey, B.W. The role of serotonin receptors in the action of atypical antipsychotic drugs. Curr. Opin. Pharmacol. 2011, 11, 59-67.
17. Shahnaz, G.; Harlt, M.; Barthelmes, J.; Leithner, K.; Sarti, F.; Hintzen, F.; Rahmat, D.; Salvenmoser, W.; Bernkop-Schnürch, A. Uptake of phenothiazines by the harvested chylomicrons ex vivo model: Influence of sel-nanoemulsifying formulation design. Eur. J. Pharm. Biopharm. 2011, 79, 171-180.
18. Aji Alexa, M.R.; Chackoa, A.J.; Josea, S.; Soutob, E.B. Lopinavir loaded solid lipid nanoparticles (SLN) for intestinal lymphatic targeting. Eur. J. Pharm. Sci. 2011, 42, 11-18.
19. Domańska, U.; Pelczarska, A.; Pobudkowska, A. Solubility and pKa determination of six structurally related phenothiazines. Int. J. Pharm. 2011, 421, 135-144.
20. Quintanar-Guerrero, D.; Fessi, H.; Allémann, E.; Doelker, E. Influence of stabilizing agents and preparatives variables on the formation of poly(DL-lactic acid) nanoparticles by an emulsification-diffusion technique. Int. J. Pharm. 1996, 143, 133-141.
21. Murakami, H.; Kobayashi, M.; Takeuchi, H.; Kawashima, Y. Preparation of poly(DL-lactide-coglycolide) nanoparticles by modified spontaneous emulsification solvent diffusion method. Int. J. Pharm. 1999, 187, 143-152.
22. Galindo-Rodriguez, S.; Alleman, E.; Fessi, H.; Doelker, E. Physicochemical parameters associated with nanoparticle formulation in the salting-out emulsification-diffusion and nanoprecipitation methods. Pharm. Res. 2004, 21, 1428-1439.
23. Nandi, A.; Khakhar, D.V.; Mehra, A. Coalescence in surfactant-stabilized emulsions subjected to shear flow. Langmuir 2001, 17, 2647-2655.
24. Tesch, S.; Schubert, H. Influence of increasing viscosity of the aqueous phase on the short-term stability of protein stabilization emulsion. J. Food Eng. 2002, 52, 305-312.
25. Song, X.; Zhao, Y.; Wu, W.; Bi, Y.; Cai, Z.; Chen, Q.; Li, Y.; Hou, S. PLGA nanoparticles simultaneously loaded with vincristine sulfate and verapamil hydrochloride: Systematic study of particle size and drug entrapment efficiency. Int. J. Pharm. 2008, 350, 320-329.
26. Kwon, H.-Y.; Lee, J.-Y.; Choi, S.-W.; Jang, Y.; Kim, J.-H. Preparation of PLGA nanoparticles containing estrogen by emulsification-diffusion method. Colloids Surf. A 2001, 182, 123-130.
27. Budhian, A.; Siegel, S.J.; Winey, K.I. Haloperidol-loaded PLGA nanoparticles: Systematic study of particle size and drug content. Int. J. Pharm. 2007, 336, 367-375.
28. Das, R.K.; Kasoju, N.; Bora, U. Encapsulation of curcumin in alginate-chitosan-pluronic composite nanoparticles for delivery to cancer cells. Nanomedicine 2010, 6, 153-160.
29. Fritze, A.; Hens, F.; Kimpfler, A.; Schubert, R.; Peschka-Suss, R. Remote loading of doxorubicin into liposomes driven by a transmembrane phosphate gradient. Biochim. Biophys. Acta 2006, 1758, 1633-1640.
30. Dunne, M.M.; Ramtoola, Z.; Corrigan, O.I. Fluphanazine release from biodegradable microparticles: Characterization and modelling of release. J. Microencapsul. 2009, 26, 403-410.
31. Domańska, U.; Halayqa, M. Promazine Hydrochloride/PLGA biodegradable nanoparticles formulation and release. J. Phys. Chem. Biophys. 2014, 4:2, 1000143.
32. Zili, Z.; Sfar, S.; Fessi, H. Preparation and characterization of poly-ε-caprolactone nanoparticles containing griseofulvin. Int. J. Pharm. 2005, 294, 261-267.
33. Huang, C.; Chen, C.; Lee, Y. Synthesis of high loading and encapsulation efficient paclitaxel-loaded poly(n-butyl cyanoacrylate) nanoparticles via miniemulsion. Int. J. Pharm. 2007, 338, 267-275.